Unibio, a Danish company developing advanced fermentation technology, has launched a refreshed visual identity as it focuses on full-scale commercialisation.
The new branding reflects Unibio’s mission to lead a global shift toward affordable, planet-friendly, and efficient protein production, delivering enhanced food security without compromising the planet’s resources. It has been developed in collaboration with Aaron Leaman and his creative studio Brighter Future.
Patented bioreactor
Unibio is known for its patented Vertical Loop Bioreactor, which is said to be efficient, scalable, and uniquely suited to protein production. Drawing inspiration from natural ecosystems, the bioreactor uses advanced fermentation processes to produce sustainable and scalable alternatives to traditional protein sources.
The technology is unaffected by changes in weather or climate and does not require arable land. It is also said to use significantly less water than the production of traditional plant proteins such as soy protein concentrate. Consequently, the bioreactor has the potential to enhance food security and provide a reliable protein source independent of conventional agriculture.
Sustainable innovation
A GFI report published earlier this year found that the global fermentation industry continues to grow, despite a drop in investments. Fermentation-derived meat, seafood, egg, and dairy companies raised $515 million globally in 2023, and though this figure was down 32% from 2022, there was a 16% increase in the number of companies in the sector.
Another report published in May found that several disruptive technologies have the potential to advance the production of fermented food and ingredients. These include continuous fermentation, lower-cost downstream processing equipment, and the standardisation of industry waste streams for fermentation growth media.
“By communicating our mission more powerfully, we ensure that Unibio stands out as a leader in sustainable innovation through both technology and product development,” says Unibio CEO David Henstrom.
